Perampanel as only add-on epilepsy treatment in elderly patients: real-world data from multicenter study

被引：0
|
作者：
Pascarella, A. [1 ]
Gasparini, S. [1 ]
Manzo, L. [1 ]
Marsico, O. [1 ]
Cianci, V. [2 ]
Ferlazzo, E. [1 ]
Aguglia, U. [1 ]
机构：
[1] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[2] Great Metropolitan Bianchi Melacrino Morelli Hosp, Reg Epilepsy Ctr, Reggio Di Calabria, Italy
[3] PEROC Study Grp, Rome, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-082
引用
收藏
页码：174 / 175
页数：2
相关论文
共 50 条
  • [31] PERAMPANEL AS ADD-ON TREATMENT IN PATIENTS WITH DRUG-RESISTANT FOCAL EPILEPSY: THE CLINICAL EXPERIENCE OF THE DANISH EPILEPSY CENTER
    Juhl, S.
    Rubboli, G.
    EPILEPSIA, 2014, 55 : 115 - 115
  • [32] Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy
    Moretz, Katherine
    Wheless, James
    Santos, Cesar
    Segal, Eric
    Lancman, Marcelo
    Patten, Anna
    Malhotra, Manoj
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2024, 50 : 23 - 30
  • [33] Defining the Optimal Treatment for Elderly Patients: Lessons from Real-World Data
    Meier, Pascal
    Gurm, Hitinder S.
    JOURNAL OF INVASIVE CARDIOLOGY, 2009, 21 (07): : 334 - 335
  • [34] Perampanel in real-world clinical care of patients with epilepsy: Interim analysis of a phase IV study
    Wheless, James
    Wechsler, Robert T.
    Lancman, Marcelo
    Aboumatar, Sami
    Patten, Anna
    Malhotra, Manoj
    EPILEPSIA OPEN, 2021, 6 (01) : 79 - 89
  • [35] Perampanel In Real-World Clinical Care Of Patients With Epilepsy: Retrospective Phase IV Study 506
    Wechsler, R. T.
    Wheless, J.
    Lancman, M.
    Aboumatar, S.
    Patten, A.
    Williams, B.
    Malhotra, M.
    EPILEPSIA, 2019, 60 : 155 - 155
  • [36] Real world experience with cannabidiol as add-on treatment in refractory epilepsy in a paediatric centre
    Quintas, S.
    Martins, R.
    Dos Santos, T. Proenca
    Coelho, J.
    Gomes, A. Levy
    EPILEPSIA, 2024, 65 : 463 - 463
  • [37] A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy
    Maguire, Melissa
    Ben-Menachem, Elinor
    Patten, Anna
    Malhotra, Manoj
    Ngo, Leock Y.
    EPILEPSY & BEHAVIOR, 2022, 126
  • [38] Perampanel monotherapy in epilepsy patients with focal and generalised seizures: real-world experience
    Alsaadi, Taoufik
    Toledo Agrany, Manuel
    Ayuga Loro, Fernando
    Trinka, Eugen
    Wu, Tony
    Malhotra, Manoj
    Ngo, Leock Y.
    Villanueva, Vicente
    EPILEPSIA, 2021, 62 : 152 - 153
  • [39] Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
    Rohracher, Alexandra
    Kalss, Gudrun
    Leitinger, Markus
    Granbichler, Claudia
    Deak, Ildiko
    Dobesberger, Judith
    Kuchukhidze, Giorgi
    Thomschewski, Aljoscha
    Hoefler, Julia
    Trinka, Eugen
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (06) : 445 - 453
  • [40] Eslicarbazepine acetate as add-on treatment to antiepileptic monotherapy in adults with partial-onset seizures: real-world data from the EPOS study
    Holtkamp, M.
    McMurray, R.
    Sousa, R.
    Kockelmann, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 63 - 63
12345